An Update on the Chemistry and Medicinal Chemistry of Novel Antimycobacterial Compounds

Title:An Update on the Chemistry and Medicinal Chemistry of Novel Antimycobacterial Compounds

Volume: 13 Issue: 22

Author(s): Frederico Silva Castelo Branco, Angelo C. Pinto and Núbia Boechat

Affiliation:

Keywords: Tuberculosis, chemistry, medicinal chemistry, novel compounds, clinical trial, Mycobacterium tuberculosis.

Abstract: Tuberculosis (TB) is a serious public health issue, particularly in underdeveloped and developing countries. Furthermore the first-line anti-TB treatments were established over 40 years ago, multidrug-resistant Mycobacterium tuberculosis strains have been developed and the risk of coinfection with AIDS virus has highlighted this disease as a global emergency. The urgent need for more effective treatments against multidrug-resistant strains compatible with anti-AIDS drugs has prompted industries, governments and non-governmental agencies to pursue new drugs. In this study, we update the portfolio listed at Stop TB Partnership, present the biological activities as well as structure-activity relationship for these drugs and thoroughly discuss the synthetic methodologies used to produce these drugs.

Cite this article as:

Branco Silva Castelo Frederico, Pinto C. Angelo and Boechat Núbia, An Update on the Chemistry and Medicinal Chemistry of Novel Antimycobacterial Compounds, Current Topics in Medicinal Chemistry 2013; 13 (22) . https://dx.doi.org/10.2174/15680266113136660201